Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis
Background: Six transmembrane epithelial antigen 1 (STEAP1) is aberrantly expressed in cancers and could therefore be a potential biomarker. This study examined the connection between STEAP1 expression and clinical features/prognosis in cancer patients. Methods: Several databases were comprehensivel...
Main Authors: | Shidi Zhao, Huan Chen, Yan Zhou, Quanfang Wang, Xiao Liang, Na Yang, Li Yan, Jin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-11-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/28/11/10.31083/j.fbl2811280 |
Similar Items
-
High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma
by: Langmei Deng, et al.
Published: (2023-03-01) -
Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal
by: Haotian Wei, et al.
Published: (2023-08-01) -
Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2
by: Kehan Chen, et al.
Published: (2023-11-01) -
Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis
by: Ting Ding, et al.
Published: (2023-01-01) -
Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration
by: João Batista-Silva, et al.
Published: (2023-01-01)